AIIMS doctors identify ‘Red Alert Zone’ to reduce risks in complex cancer surgery
The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach- Aayush Wellness launches calcium, vitamin supplements; enters USD 16.3-bn bone & joint health segment
- NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9
- -3.540.400.5015.77
- -3.590.120.1815.60
- -3.77-0.090.0415.56
- Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic research
- NITI Aayog explores policies to boost India's medical and dental device manufacturing industry
- From lifespan to healthspan: How Abu Dhabi and India can make prevention practical
- HLL Lifecare launches eStore to expand direct-to-consumer reach
- AYUSH sees rise in patents filings showcasing innovation growth; 4,077 applications filed from 2014 to 2026
- India needs 2.6 billion sq ft of healthcare space by 2035, says CBRE
- Indian, German firms to collaborate on immunoglobulin products: Indian Embassy
- Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launch
- Novo Holdings, GIC, Axight look to back AIG Hospitals; Founders aim to pare 10-12% stake at Rs 24,000 cr valuation
- Health ministry asked to examine coronary stent safety concerns
- Biocon clears path for cancer drug launch
Top Mutual Funds
3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)
MORE NEWS
Biotech
FSSAI pulls up Dr Reddy's, Nestle Health Science over Celevida claims- Lord’s Mark strengthens UK and UK allied market strategy with regulatory backing for IVD portfolio.
- NDude Labs invests in nutraceutical ingredients firm Nutriventia
- MSD inaugurates 2.5 lakh sq ft tech centre in Hyderabad
- Govt eases loan licence requirement for 'outsourced' sterilisation of medical gear
Healthcare
- AIIMS doctors identify ‘Red Alert Zone’ to reduce risks in complex cancer surgery
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach
- Aayush Wellness launches calcium, vitamin supplements; enters USD 16.3-bn bone & joint health segment
- Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic research
- NITI Aayog explores policies to boost India's medical and dental device manufacturing industry
Pharmaceuticals
NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9- Biocon clears path for cancer drug launch
- Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growth
- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possible
- Assessing products to counter side effects of GLP-1, says Bayer's Triana